Insufficient scRNA-seq data for expression of CTH at single-cell level.
Insufficient scRNA-seq data for expression of CTH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 346.03 | 243 / 245 | 100% | 13.05 | 501 / 502 |
brain | 98% | 285.96 | 2595 / 2642 | 100% | 11.46 | 702 / 705 |
liver | 100% | 5170.61 | 226 / 226 | 95% | 76.87 | 385 / 406 |
stomach | 100% | 485.82 | 358 / 359 | 94% | 8.99 | 270 / 286 |
ovary | 100% | 3184.00 | 180 / 180 | 90% | 4.54 | 389 / 430 |
breast | 100% | 252.92 | 457 / 459 | 91% | 5.85 | 1014 / 1118 |
intestine | 94% | 217.18 | 906 / 966 | 95% | 9.72 | 502 / 527 |
kidney | 100% | 425.38 | 89 / 89 | 87% | 5.12 | 788 / 901 |
lung | 94% | 316.14 | 542 / 578 | 93% | 8.86 | 1073 / 1155 |
thymus | 100% | 675.19 | 653 / 653 | 85% | 5.10 | 516 / 605 |
pancreas | 100% | 502.95 | 328 / 328 | 83% | 3.71 | 147 / 178 |
skin | 76% | 207.76 | 1382 / 1809 | 97% | 11.90 | 456 / 472 |
bladder | 95% | 207.81 | 20 / 21 | 73% | 4.99 | 369 / 504 |
esophagus | 87% | 236.81 | 1254 / 1445 | 76% | 5.85 | 139 / 183 |
uterus | 97% | 276.78 | 165 / 170 | 64% | 4.06 | 295 / 459 |
adrenal gland | 99% | 945.40 | 255 / 258 | 52% | 3.47 | 119 / 230 |
adipose | 98% | 318.94 | 1182 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 448.17 | 1300 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 6.21 | 72 / 80 |
muscle | 80% | 171.62 | 640 / 803 | 0% | 0 | 0 / 0 |
spleen | 72% | 89.04 | 174 / 241 | 0% | 0 | 0 / 0 |
heart | 67% | 122.24 | 581 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 60% | 2.28 | 27 / 45 |
lymph node | 0% | 0 | 0 / 0 | 52% | 3.18 | 15 / 29 |
peripheral blood | 32% | 296.35 | 297 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0018272 | Biological process | protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine |
GO_0019346 | Biological process | transsulfuration |
GO_0006534 | Biological process | cysteine metabolic process |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0019344 | Biological process | cysteine biosynthetic process |
GO_0019343 | Biological process | cysteine biosynthetic process via cystathionine |
GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0070814 | Biological process | hydrogen sulfide biosynthetic process |
GO_0044524 | Biological process | protein sulfhydration |
GO_2001234 | Biological process | negative regulation of apoptotic signaling pathway |
GO_1904831 | Biological process | positive regulation of aortic smooth muscle cell differentiation |
GO_0006629 | Biological process | lipid metabolic process |
GO_0051289 | Biological process | protein homotetramerization |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0030170 | Molecular function | pyridoxal phosphate binding |
GO_0044540 | Molecular function | L-cystine L-cysteine-lyase (deaminating) |
GO_0004123 | Molecular function | cystathionine gamma-lyase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0080146 | Molecular function | L-cysteine desulfhydrase activity |
GO_0047982 | Molecular function | homocysteine desulfhydrase activity |
GO_0098606 | Molecular function | selenocystathionine gamma-lyase activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CTH |
Protein name | Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2) |
Synonyms | |
Description | FUNCTION: Catalyzes the last step in the trans-sulfuration pathway from L-methionine to L-cysteine in a pyridoxal-5'-phosphate (PLP)-dependent manner, which consists on cleaving the L,L-cystathionine molecule into L-cysteine, ammonia and 2-oxobutanoate . Part of the L-cysteine derived from the trans-sulfuration pathway is utilized for biosynthesis of the ubiquitous antioxidant glutathione . Besides its role in the conversion of L-cystathionine into L-cysteine, it utilizes L-cysteine and L-homocysteine as substrates (at much lower rates than L,L-cystathionine) to produce the endogenous gaseous signaling molecule hydrogen sulfide (H2S) . In vitro, it converts two L-cysteine molecules into lanthionine and H2S, also two L-homocysteine molecules to homolanthionine and H2S, which can be particularly relevant under conditions of severe hyperhomocysteinemia (which is a risk factor for cardiovascular disease, diabetes, and Alzheimer's disease) . Lanthionine and homolanthionine are structural homologs of L,L-cystathionine that differ by the absence or presence of an extra methylene group, respectively . Acts as a cysteine-protein sulfhydrase by mediating sulfhydration of target proteins: sulfhydration consists of converting -SH groups into -SSH on specific cysteine residues of target proteins such as GAPDH, PTPN1 and NF-kappa-B subunit RELA, thereby regulating their function . By generating the gasotransmitter H2S, it participates in a number of physiological processes such as vasodilation, bone protection, and inflammation (Probable) . Plays an essential role in myogenesis by contributing to the biogenesis of H2S in skeletal muscle tissue (By similarity). Can also accept homoserine as substrate (By similarity). Catalyzes the elimination of selenocystathionine (which can be derived from the diet) to yield selenocysteine, ammonia and 2-oxobutanoate (By similarity). . |
Accessions | P32929 ENST00000411986.6 [P32929-3] ENST00000346806.2 [P32929-2] ENST00000370938.8 [P32929-1] |